COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,673 Articles (22,913 medRxiv, 8,760 bioRxiv)

Most recent first Previous |  Page 447: Articles 4461-4470  | Next

Polygenic risk of idiopathic pulmonary fibrosis and COVID-19 severity
Guillen-Guio, B., Marcelino-Rodriguez, I., Lorenzo-Salazar, J. M., Leavy, O. C., Allen, R. J., Scourge Cohort Group, , Riancho, J. A., Rojas, A., Lapunzina, P., Carracedo, A., Wain, L. V., Flores, C.
10.1101/2023.06.12.23291269 — Posted: 2023-06-13
Choroid plexus defects in Down syndrome brain organoids enhance neurotropism of SARS-CoV-2
Shaker, M. R., Slonchak, A., Al-mhanawi, B., Morrison, S. D., Sng, J. D. J., Cooper-White, J. J., Khromykh, A. A., Wolvetang, E. J.
10.1101/2023.06.12.544552 — Posted: 2023-06-12
Improving modelling for epidemic responses: reflections from members of the UK infectious disease modelling community on their experiences during the COVID-19 pandemic
Sherratt, K., Carnegie, A. C., Kucharski, A., Cori, A., Pearson, C. A., Jarvis, C. I., Overton, C., Weston, D., Hill, E. M., Knock, E., Fearon, E., Nightingale, E., Hellewell, J., Edmunds, W. J., Arenas, J. V., Prem, K., Pi, L., Baguelin, M., Kendall, M., Ferguson, N., Davies, N., Eggo, R. M., van Elsland, S., Russell, T., Funk, S., Liu, Y., Abbott, S.
10.1101/2023.06.12.544667 — Posted: 2023-06-12
RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways
Gagne, M., Flynn, B. J., Honeycutt, C. C., Flebbe, D. R., Andrew, S. F., Provost, S. J., McCormick, L., Van Ry, A., McCarthy, E., Todd, J.-P. M., Bao, S., Teng, I.-T., Marciano, S., Rudich, Y., Li, C., Pessaint, L., Dodson, A., Cook, A., Lewis, M. G., Andersen, H., Zahradnik, J., Nason, M. C., Foulds, K. E., Kwong, P. D., Roederer, M., Schreiber, G., Seder, R. A., Douek, D. C.
10.1101/2023.06.09.544432 — Posted: 2023-06-12
Importation models for travel-related SARS-CoV-2 cases reported in Newfoundland and Labrador during the COVID-19 pandemic
Mohammadi, Z., Cojocaru, M. G., Arino, J., Hurford, A.
10.1101/2023.06.08.23291136 — Posted: 2023-06-12
Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults
Tandler, C., Heitmann, J. S., Michael, T. M., Marconato, M., Jaeger, S. U., Tegeler, C. M., Denk, M., Richter, M., Oezbek, M. T., Maringer, Y., Schroeder, S. M., Schneiderhan-Marra, N., Wiesmueller, K.-H., Bitzer, M., Ruetalo, N., Schindler, M., Meisner, C., Fischer, I., Rammensee, H.-G., Salih, H. R., Walz, J. S.
10.1101/2023.06.07.23291074 — Posted: 2023-06-12
Quantitatively assessing early detection strategies for mitigating COVID-19 and future pandemics
Liu, A. B., Lee, D., Jalihal, A. P., Hanage, W. P., Springer, M.
10.1101/2023.06.08.23291050 — Posted: 2023-06-12
SARS-CoV-2 infections among 12 000 pregnant women, 2020, Finland - cross-testing of neutralization assays
Virtanen, J., Korhonen, E. M., Salonen, S., Vapalahti, O., Sironen, T., Jaaskelainen, A. J.
10.1101/2023.06.07.23290927 — Posted: 2023-06-12
Trends in medication use after the onset of the COVID-19 pandemic in the Republic of Ireland: an interrupted time series study
Mattsson, M., Hong, J. A., Frazer, J. S., Frazer, G. R., Moriarty, F.
10.1101/2023.06.09.23291202 — Posted: 2023-06-12
Impact of COVID-19 Pandemic on Sleep Including HRV and Physical Activity as Mediators: A Causal ML Approach
Khatibi, E., Abbasian, M., Azimi, I., Labbaf, S., Feli, M., Borelli, J., Dutt, N., Rahmani, A.
10.1101/2023.06.08.23291008 — Posted: 2023-06-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).